Continuous renal replacement therapy to reduce inflammation in a piglet hemorrhage-reperfusion extracorporeal membrane oxygenation model

Pediatric Research

Volumn 72, Issue 3, 2012, Pages 249-255

  Mu, Thornton S ^a   Palmer, Eldon G ^a   Batts, Sherreen G ^a   Lentz Kapua, Sarah L ^a   Uyehara Lock, Jane H ^b   Uyehara, Catherine F T ^a  

^a TRIPLER ARMY MEDICAL CENTER   (United States)

^b UNIVERSITY OF HAWAII   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLEEDING; BLOOD FLOW; BLOOD VOLUME; CONTINUOUS RENAL REPLACEMENT THERAPY; CONTROLLED STUDY; DISEASE MODEL; EXTRACORPOREAL OXYGENATION; HEART OUTPUT; HEMODYNAMIC PARAMETERS; INFLAMMATION; LUNG LAVAGE; LUNG PARENCHYMA; MEAN ARTERIAL PRESSURE; NONHUMAN; OXYGEN CONSUMPTION; PIGLET; PRIORITY JOURNAL; REPERFUSION INJURY; SYSTEMIC VASCULAR RESISTANCE;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; DISEASE MODELS, ANIMAL; EXTRACORPOREAL MEMBRANE OXYGENATION; HEMODYNAMICS; INFLAMMATION; OXYGEN; RENAL REPLACEMENT THERAPY; SWINE;

EID: 84865322136     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1038/pr.2012.69     Document Type: Article

References (28)

1. Fortenberry JD, Paden ML. Extracorporeal therapies in the treatment of sepsis: experience and promise. Semin Pediatr Infect Dis 2006;17:72-9. (Pubitemid 43963529)
2. Ford JW. Neonatal ECMO: current controversies and trends. Neonatal Netw 2006;25:229-38.
3. Fortenberry JD, Bhardwaj V, Niemer P, Cornish JD, Wright JA, Bland L. Neutrophil and cytokine activation with neonatal extracorporeal membrane oxygenation. J Pediatr 1996;128(5 Pt 1):670-8. (Pubitemid 26137726)
4. Massoudy P, Zahler S, Becker BF, Braun SL, Barankay A, Meisner H. Evidence for inflammatory responses of the lungs during coronary artery bypass grafting with cardiopulmonary bypass. Chest 2001;119:31-6. (Pubitemid 32150544)
5. Mildner RJ, Taub N, Vyas JR, et al. Cytokine imbalance in infants receiving extracorporeal membrane oxygenation for respiratory failure. Biol Neonate 2005;88:321-7. (Pubitemid 41642757)
6. Golej J, Winter P, Schoffmann G, et al. Impact of extracorporeal membrane oxygenation modality on cytokine release during rescue from infant hypoxia. Shock 2003;20:110-5.
7. Adrian K, Mellgren K, Skogby M, Friberg LG, Mellgren G, Wadenvik H. Cytokine release during long-term extracorporeal circulation in an experimental model. Artif Organs 1998;22:859-63. (Pubitemid 28471277)
8. Marti F, Munoz J, Peiro M, et al. Higher cytotoxic activity and increased levels of IL-1 beta, IL-6, and TNF-alpha in patients undergoing cardiopulmonary bypass. Am J Hematol 1995;49:237-9.
9. Cavagnaro F, Kattan J, Godoy L, et al. Continuous renal replacement therapy in neonates and young infants during extracorporeal membrane oxygenation. Int J Artif Organs 2007;30:220-6. (Pubitemid 46739049)
10. ECMO Registry of the Extracorporeal Life Support Organization (ELSO). Ann Arbor, Michigan 2010.
11. Rushing GD, Britt LD. Reperfusion injury after hemorrhage: a collective review. Ann Surg 2008;247:929-37. (Pubitemid 351771334)
12. Schetz M. Non-renal indications for continuous renal replacement therapy. Kidney Int Suppl 1999;56:88-94.
13. Matsuda K, Hirasawa H, Oda S, Shiga H, Nakanishi K. Current topics on cytokine removal technologies. Ther Apher 2001;5:306-14. (Pubitemid 33062680)
14. Prowle JR, Bellomo R. Continuous renal replacement therapy: recent advances and future research. Nat Rev Nephrol 2010;6:521-9.
15. Nakada TA, Oda S, Matsuda K, et al. Continuous hemodiafiltration with PMMA Hemofilter in the treatment of patients with septic shock. Mol Med 2008;14:257-63. (Pubitemid 351785698)
16. Shaheen IS, Harvey B, Watson AR, Pandya HC, Mayer A, Thomas D. Continuous venovenous hemofiltration with or without extracorporeal membrane oxygenation in children. Pediatr Crit Care Med 2007;8:362-5. (Pubitemid 47057686)
17. Symons JM, Chua AN, Somers MJ, et al. Demographic characteristics of pediatric continuous renal replacement therapy: a report of the prospective pediatric continuous renal replacement therapy registry. Clin J Am Soc Nephrol 2007;2:732-8.
18. Ricci Z, Polito A, Giorni C, Di Chiara L, Ronco C, Picardo S. Continuous hemofiltration dose calculation in a newborn patient with congenital heart disease and preoperative renal failure. Int J Artif Organs 2007;30:258-61. (Pubitemid 46739054)
19. Paden ML, Warshaw BL, Heard ML, Fortenberry JD. Recovery of renal function and survival after continuous renal replacement therapy during extracorporeal membrane oxygenation. Pediatr Crit Care Med 2011;12:153-8.
20. Santiago MJ, Sanchez A, Lopez-Herce J, et al. The use of continuous renal replacement therapy in series with extracorporeal membrane oxygenation. Kidney Int 2009;76:1289-92.
21. Lu GP, Gong JY, Lu ZJ, Zhang LE, Kissoon N. Effect of continuous venovenous hemodiafiltration on endotoxin-induced acute lung injury of the piglets. Pediatr Crit Care Med 2011;12:e73-8.
22. Skogby M, Adrian K, Friberg LG, Mellgren G, Mellgren K. Influence of hemofiltration on plasma cytokine levels and platelet activation during extra corporeal membrane oxygenation. Scand Cardiovasc J 2000;34:315-20.
23. Kotani N, Hashimoto H, Sessler DI, et al. Cardiopulmonary bypass produces greater pulmonary than systemic proinflammatory cytokines. Anesth Analg 2000;90:1039-45. (Pubitemid 30253447)
24. Calkovska A, Mokra D, Drgova A, Zila I, Javorka K. Bronchoalveolar lavage with pulmonary surfactant/dextran mixture improves meconium clearance and lung functions in experimental meconium aspiration syndrome. Eur J Pediatr 2008;167:851-7. (Pubitemid 351904588)
25. Lista G, Bianchi S, Castoldi F, Fontana P, Cavigioli F. Bronchoalveolar lavage with diluted porcine surfactant in mechanically ventilated term infants with meconium aspiration syndrome. Clin Drug Investig 2006;26:13-9. (Pubitemid 43098404)
26. Mildner RJ, Taub NA, Vyas JR, et al. Repeatability of cellular constituents and cytokine concentration in fluid obtained by non-bronchoscopic bronchoalveolar lavage of infants receiving extracorporeal oxygenation. Thorax 2001;56:924-31. (Pubitemid 33097186)
27. Balaraman V, Meister J, Ku TL, et al. Lavage administration of dilute surfactants after acute lung injury in neonatal piglets. Am J Respir Crit Care Med 1998;158:12-7. (Pubitemid 28337151)
28. Brophy PD, Mottes TA, Kudelka TL, et al. AN-69 membrane reactions are pH-dependent and preventable. Am J Kidney Dis 2001;38:173-8. (Pubitemid 32611775)